The News
Esmertec forecasts 2006 revenues of over USD 24 million
21/11/2006
Michel Kuntz appointed EVP Sales to strengthen the organization’s market-driven approach
DUEBENDORF-ZURICH, Switzerland - November 21, 2006 – Esmertec™ (SWX: ESMN), a focused provider of software and services to communications device manufacturers and mobile telecom operators, is pleased to announce today that Michel Kuntz joins Esmertec, effective January 1, 2007, in the role of Executive Vice President Sales, responsible for driving Esmertec's sales organization globally. Before joining Esmertec, Michel Kuntz , 42, was Vice President Marketing and Sales EMAI and Latin America at Thomson Broadband from 2002 and before that was Vice President Marketing and Sales EMAI at Alcatel Mobile Phones & Broadband Access. He has 19 years work experience primarily in the telecommunications and technology sector.
The product development and marketing organization is being reorganized with the product line managers of both segments and a VP marketing reporting directly to the CEO. Georges Boulloy , who was instrumental in the reorganization process, will leave the Company and the position of Chief Product Officer will be eliminated. The company thanks George Boulloy for his important contribution during the past months, helping to chart the course for the company to become more market-driven.
Jean-Claude Martinez, CEO of Esmertec, comments: “We are very pleased to have such an experienced industry expert as Michel Kuntz coming on board. We believe this management extension, together with the expected strengthening of our board, is a strong sign of Esmertec's business potential.”
After further operational reviews and in line with the product organization change mentioned above, management has decided to take additional actions to make Esmertec's product management and development operations more efficient. Esmertec's product management function for the Mobile & Multimedia Device Segment is henceforth planned to be managed centrally in Zurich , with certain positions currently located in the UK moving to Zurich . Additionally, consistent with Esmertec's policy of having customer services based close to its customers, certain project management functions currently based in the UK , but supporting US customers, will be moved to the US . Consequently, alternatives for the company's UK office are being evaluated in accordance with local legal requirements in the UK .
Business in the third quarter showed a solid pick-up. In particular, in the Mobile & Multimedia Device Segment shipments by customers in the third quarter increased to over 18 million compared with 10.4 million in the second quarter and 5.9 million in the third quarter of 2005. Third quarter shipments represent an estimated 7.2% share of the total mobile phone market, up from 4.4% in the second quarter of 2006 and 2.8% in the third quarter of 2005. Third quarter 2006 performance reflects strong shipments by large customers in preparation for the holiday season and Esmertec does not expect the same growth of shipments necessarily to continue in the fourth quarter. As of September 30, 2006, Esmertec's software has been deployed on over 340 mobile and embedded device models world-wide and over 76 million units had been shipped.
Esmertec now expects revenue of at least USD 14.5 million for the second half year, and consequently revenues of at least USD 24 million for the full year 2006. The current status of several new contracts and renewals in both segments support this outlook. Based on this information, Esmertec confirms previous guidance that it expects to begin generating cash from operations in the first half of 2007.
This communication contains forward-looking statements based on current expectations and assumptions of the company's management only, and involve certain risks and uncertainties. The forward-looking statements contained herein could be substantially impacted by risks and influences that are not foreseeable at present, so that actual results may vary materially from those anticipated, expected, or projected. Esmertec disclaims any intention or obligation to update and revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About Esmertec
Esmertec is a focused provider of software and services to communications device manufacturers and mobile telecom operators . The company provides software platforms that enable the deployment of content and applications in devices and over servers. Customers include mobile telecom operators and manufacturers of mobile handsets, set-top boxes and interactive televisions. Esmertec's software and service capabilities excel with its reliability as well as fast and local execution. Founded in 1999, Esmertec is headquartered in Zurich , Switzerland with subsidiaries in China , France , South Korea , and the USA , and offices in Taiwan and the UK . Since 2005, Esmertec has been listed on the SWX Swiss Exchange (ESMN).
Investor relations contact
Deborah Choate, CFO
Phone +41 44 823 8954
dchoate@esmertec.com
Media Contact
Jan Gregor
IR Firm
Phone + 41 43 244 8154
jan.gregor@irfirm.biz
Esmertec, Jbed and OSVM are trademarks of Esmertec AG. Java is a trademark of Sun Microsystems, Inc. Other names may be trademarks of their respective owners.
2006
-
18/01/2006
Ablynx announces pharma alliance to develop therapeutic Nanobodies™
-
23/01/2006
Sofinnova et Apax Partners investissent 12 millions d'euros dans DBV Technologies
-
23/01/2006
Sofinnova and Apax Partners invest €12 million in DBV Technologies
- 24/01/2006
-
24/01/2006
Emailvision files for an IPO on the Euronext Paris Alternext stock market.
-
24/01/2006
Varioptic announces general availability of the Artic 320 liquid lens for camera-phones
- 24/01/2006
- 24/01/2006
- 31/01/2006
- 03/02/2006
-
03/02/2006
Sofinnova Partners takes two prizes in prestigious EVJC awards event
-
03/02/2006
La richesse et les performances Java d’Esmertec à présent disponibles sur AJAR de TTPCom
- 03/02/2006
-
08/02/2006
Emailvision Announces Successful IPO On Euronext Paris Alternext Market.
- 08/02/2006
-
13/02/2006
Lectus Therapeutics closes Series A funding round raising £8.2 million
- 15/02/2006
-
01/03/2006
CoreValve names J. C. MacRae as Vice President of Finance and Chief Financial Officer
-
28/02/2006
Faust Pharmaceuticals nomme Thomas C. Seoh au poste de directeur général
-
02/03/2006
NicOx conclut un nouvel accord majeur avec Pfizer pour des composés donneurs de NO en ophtalmologie
-
02/03/2006
NicOx signs major new agreement with Pfizer for NOdonating compounds in ophthalmology
- 09/03/2006
- 14/03/2006
- 14/03/2006
-
14/03/2006
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
- 24/03/2006
- 27/03/2006
- 28/03/2006
-
28/03/2006
Diatos Announces Expansion of Medarex Cancer Product Licensing Agreement
-
24/03/2006
Esmertec apporte au marché M2M une solution logicielle client-serveur unique – OSVM Universe
- 28/03/2006
-
10/04/2006
Endoart SA Completes US$ 10.5 million (CHF 13.5 million) Venture Financing Round
- 26/04/2006
-
26/04/2006
Endoart's remote-controlled gastric band gets .5m injection of private money
- 19/04/2006
-
02/05/2006
Barrett Katz, MD, MBA, Appointed EVP & CMO of Fovea Pharmaceuticals
- 27/04/2006
- 27/04/2006
-
25/04/2006
Varioptic lève 16.4 millions d’euros ($20m) pour son troisième tour de table
-
25/04/2006
Varioptic Secures € 16.4 million (USD 20m) in Third Round of Financing
-
19/04/2006
Fidelity Investments International acquiert près de 10% du capital d’Emailvision
- 04/05/2006
- 04/05/2006
-
03/05/2006
Cotherix Inc. : Net Sales Increase 32 Percent Over Previous Quarter
- 10/05/2006
-
11/05/2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome® from Gilead Sciences
- 11/05/2006
- 09/05/2006
- 11/05/2006
- 15/06/2006
- 15/05/2006
- 02/05/2006
-
10/05/2006
Samsung selects 6Wind software to develop mobile IP applications
-
10/05/2006
Samsung selectionne 6Wind pour développer des applications de mobilité IP
- 17/05/2006
- 18/05/2006
- 16/05/2006
- 03/05/2006
- 18/05/2006
-
18/05/2006
Prévision d'une baisse importante du chiffre d'affaires au premier semestre 2006
-
17/05/2006
BASF Plant Science acquires Belgian biotechnology company CropDesign.
- 29/05/2006
-
11/05/2006
Diatos Annonce l’Acquisition du Médicament Oncologique DaunoXome® auprès de Gilead Sciences
-
11/05/2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome® from Gilead Sciences
-
06/06/2006
Varioptic finalise son tour de table avec la participation de Dow Corporate Venture Capital
- 06/06/2006
- 13/06/2006
-
15/05/2006
UPEK Recognized as 2006 Laureate by The Computerworld Honors Program
- 19/06/2006
- 28/06/2006
- 08/06/2006
-
07/07/2006
Varioptic etend sa gamme de solutions autofocus avec Artic 416
- 06/07/2006
- 02/08/2006
- 02/08/2006
- 17/07/2006
- 17/07/2006
- 29/08/2006
-
28/08/2006
Travel Meta Search receives financing round from Sofinnova Partners and Walden International
-
30/08/2006
Esmertec announces results for the half-year ended June 30, 2006
-
30/08/2006
Addex commences Phase II clinical trials programme with ADX10059
- 05/09/2006
- 23/08/2006
- 23/08/2006
- 11/09/2006
- 11/09/2006
- 11/09/2006
- 26/09/2006
- 05/10/2006
-
05/10/2006
WYPLAY SAS reçoit un financement de 4 millions d’euros de la part de Sofinnova Partners
-
05/10/2006
WYPLAY SAS receives €4 million financing round from Sofinnova Partners
- 09/10/2006
- 09/10/2006
-
09/10/2006
Esmertec annonce la cession de sa participation majoritaire dans sa filiale japonaise
-
09/10/2006
Esmertec Announces Sale of Majority Stake in Japanese Subsidiary
- 10/10/2006
- 10/10/2006
- 10/10/2006
-
17/10/2006
Inside Contactless selected as finalist to receive cartes 2006 Best Hardware sesame award
- 19/10/2006
-
16/10/2006
UPEK Receives First FIPS 201 Certification for Silicon Fingerprint Sensors
- 20/10/2006
- 20/10/2006
-
18/10/2006
VoluBill signs new deal with major mobile operator in Northern Africa
- 24/10/2006
- 24/10/2006
-
24/10/2006
Corevalve's 18-french revalving™ system demonstrated 'live' at TCT 2006
-
02/11/2006
Launch of Blyk Heralds a New Opportunity in Mobile Advertising
- 06/11/2006
- 06/11/2006
- 13/11/2006
-
13/11/2006
Cerenis Therapeutics clôt un tour de financement record de 42.1 millions d'euros
- 13/11/2006
-
13/11/2006
Initial Clinical Experience with Telemetrically Adjustable Gastric Banding
- 21/11/2006
-
21/11/2006
Esmertec forecasts 2006 revenues of over USD 24 million
-
30/11/2006
Esmertec’s Jbed Software Deployed in LG Electronics’ Highly Successful GSM-based Chocolate Phone
-
05/12/2006
Esmertec and Yuhua TelTech Set New Benchmark with 1-stop Solution for Linux®-Based Mobile Devices
- 21/12/2006
- 22/02/2006
-
21/02/2006
Stentys appoints Luc Morisset as Director of Regulatory Affairs
- 28/02/2006